Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase 1 Study of alisertib (MLN8237) in combination with mFOLFOX in gastrointestinal tumorsCIRB: Adult CIRB - Early Phase EmphasisLead Group: ETCTNStatus: CompletedReview Status: Completed